AT
EXAS

American Trust’s Exact Sciences EXAS Stock Holding History

American Trust’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,359
Closed -$229K – 319
2024
Q3 		$229K Buy
+3,359
New +$190K 0.02% 233
2024
Q2 		– Sell
-3,019
Closed -$208K – 262
2024
Q1 		$208K Buy
+3,019
New +$191K 0.02% 265
2023
Q3 		– Sell
-3,345
Closed -$314K – 323
2023
Q2 		$314K Sell
3,345
-682
-17% -$53.2K 0.02% 296
2023
Q1 		$273K Sell
4,027
-125
-3% -$8.04K 0.02% 334
2022
Q4 		$206K Sell
4,152
-14,681
-78% -$600K 0.02% 408
2022
Q3 		$612K Buy
18,833
+1,055
+6% +$43.5K 0.05% 164
2022
Q2 		$700K Sell
17,778
-2,131
-11% -$114K 0.06% 165
2022
Q1 		$1.39M Buy
19,909
+16,555
+494% +$1.21M 0.09% 119
2021
Q4 		$261K Buy
+3,354
New +$296K 0.02% 270

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Trust's EXAS Position: Q4 2024 in Review

American Trust sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 3,359 shares — an estimated $229K sold.

American Trust first reported a position in EXAS in Q4 2021 and held it in 9 quarters. The position peaked at $1.39M in Q1 2022. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • American Trust reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • American Trust sold 3,359 Exact Sciences shares in Q4 2024, an estimated $229K.
  • American Trust first reported a position in Exact Sciences in Q4 2021 and held it in 9 quarters.
  • American Trust's Exact Sciences position peaked at $1.39M in Q1 2022.
  • 593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on American Trust's 13F filing for Q4 2024, filed 18 Feb 2025.